Related references
Note: Only part of the references are listed.Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms
Melanie S. Brennan et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Mackenzie A. Michell-Robinson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi et al.
ACTA NEUROPATHOLOGICA (2015)
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE
Hui Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism
Stefan Dibbert et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Meijuan Zhang et al.
PROGRESS IN NEUROBIOLOGY (2013)
Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
R. Gold et al.
CLINICAL IMMUNOLOGY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke
Alessio Alfieri et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling
Mehrdad Ghashghaeinia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Ethanol-induced HO-1 and NQO1 Are Differentially Regulated by HIF-1α and Nrf2 to Attenuate Inflammatory Cytokine Expression
Samantha M. Yeligar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action
Martin Rostami-Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
Hua Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells
Subbiah Pugazhenthi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress
Jianyong Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Multiple sclerosis: Advances in understanding, diagnosing, and treating the underlying disease
RJ Fox et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2006)
Disease-modifying drugs for multiple sclerosis: current and future aspects
Mark S. Freedman
EXPERT OPINION ON PHARMACOTHERAPY (2006)
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
Y Gilgun-Sherki et al.
JOURNAL OF NEUROLOGY (2004)
The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress
T Nguyen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Pharmacokinetics of oral fumarates in healthy subjects
NHR Litjens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters
D Werdenberg et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H: quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence
P Nioi et al.
BIOCHEMICAL JOURNAL (2003)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
